Philip Meade

5.7k total citations · 1 hit paper
23 papers, 1.5k citations indexed

About

Philip Meade is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Philip Meade has authored 23 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 8 papers in Infectious Diseases and 6 papers in Immunology. Recurrent topics in Philip Meade's work include Influenza Virus Research Studies (15 papers), Respiratory viral infections research (12 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Philip Meade is often cited by papers focused on Influenza Virus Research Studies (15 papers), Respiratory viral infections research (12 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Philip Meade collaborates with scholars based in United States, Austria and United Kingdom. Philip Meade's co-authors include Florian Krammer, Fatima Amanat, Shirin Strohmeier, Viviana Simon, Meagan McMahon, Daniel Stadlbauer, Veronika Chromikova, Judith A. Aberg, Kimberly Muellers and Kimberly Stone and has published in prestigious journals such as Science, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Philip Meade

19 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

2020 648 citations Ania Wajnberg, Fatima Amanat et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip Meade United States	11	1.2k	373	229	162	151	23	1.5k
Frauke Muecksch United States	12	1.3k 1.1×	131 0.4×	198 0.9×	322 2.0×	148 1.0×	20	1.5k
Victoria A. Avanzato United States	12	1.1k 1.0×	209 0.6×	109 0.5×	156 1.0×	140 0.9×	20	1.3k
Jessica Tan United States	10	498 0.4×	329 0.9×	167 0.7×	120 0.7×	63 0.4×	16	796
Kerri St. Denis United States	12	1.7k 1.5×	105 0.3×	291 1.3×	486 3.0×	196 1.3×	18	1.9k
C Tham Singapore	12	1.7k 1.5×	272 0.7×	501 2.2×	409 2.5×	190 1.3×	18	2.1k
Guha Asthagiri Arunkumar United States	10	468 0.4×	204 0.5×	136 0.6×	88 0.5×	64 0.4×	12	670
Lianlian Bian China	16	833 0.7×	269 0.7×	176 0.8×	361 2.2×	78 0.5×	41	1.4k
Felicity Chandler Netherlands	7	1.1k 1.0×	76 0.2×	67 0.3×	116 0.7×	106 0.7×	17	1.2k
Prudence Kgagudi South Africa	7	685 0.6×	92 0.2×	69 0.3×	185 1.1×	52 0.3×	10	797
Sylvie Behillil France	17	598 0.5×	388 1.0×	63 0.3×	78 0.5×	173 1.1×	27	1.1k

Countries citing papers authored by Philip Meade

Since Specialization

Citations

This map shows the geographic impact of Philip Meade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Meade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Meade more than expected).

Fields of papers citing papers by Philip Meade

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Meade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Meade. The network helps show where Philip Meade may publish in the future.

Co-authorship network of co-authors of Philip Meade

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Meade. A scholar is included among the top collaborators of Philip Meade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Meade. Philip Meade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carreño, Juan Manuel, Philip Meade, Kaori Sano, et al.. (2025). Induction of hemagglutinin stalk reactive antibodies by the administration of a live-attenuated influenza virus vaccine in children. iScience. 28(7). 112893–112893.

Hao, Stephanie P., Benjamin B. Lindsey, Ya Jankey Jagne, et al.. (2025). Integrative mapping of preexisting influenza immune landscapes predicts vaccine response. Journal of Clinical Investigation. 135(18).

Okba, Nisreen M.A., Jessica Tan, Philip Meade, et al.. (2024). Broadly protective bispecific antibodies that simultaneously target influenza virus hemagglutinin and neuraminidase. mBio. 15(7). e0108524–e0108524. 2 indexed citations

Artiaga, Bianca L., Daniel W. Madden, Taeyong Kwon, et al.. (2024). Adjuvant Use of the Invariant-Natural-Killer-T-Cell Agonist α-Galactosylceramide Leads to Vaccine-Associated Enhanced Respiratory Disease in Influenza-Vaccinated Pigs. Vaccines. 12(9). 1068–1068.

Sidney, John, A-Reum Kim, Rory D. de Vries, et al.. (2024). Targets of influenza human T-cell response are mostly conserved in H5N1. mBio. 16(2). e0347924–e0347924. 4 indexed citations

Amanat, Fatima, Jordan J Clark, Juan Manuel Carreño, et al.. (2023). Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2 Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated by COVID-19 mRNA Vaccination. Journal of Virology. 97(3). e0166422–e0166422. 9 indexed citations

Reeth, Kristien Van, Ivan Trus, Koen Chiers, et al.. (2023). Sequential vaccinations with divergent H1N1 influenza virus strains induce multi-H1 clade neutralizing antibodies in swine. Nature Communications. 14(1). 7745–7745. 2 indexed citations

Goll, Johannes B., Aarti Jain, Rie Nakajima, et al.. (2022). The antibody landscapes following AS03 and MF59 adjuvanted H5N1 vaccination. npj Vaccines. 7(1). 103–103. 16 indexed citations

Meade, Philip, Shirin Strohmeier, Maria C. Bermúdez‐González, et al.. (2022). Antigenic Landscape Analysis of Individuals Vaccinated with a Universal Influenza Virus Vaccine Candidate Reveals Induction of Cross-Subtype Immunity. Journal of Virology. 97(1). e0107022–e0107022. 6 indexed citations

10.

Amanat, Fatima, Shirin Strohmeier, Philip Meade, et al.. (2021). Vaccination with SARS-CoV-2 variants of concern protects mice from challenge with wild-type virus. PLoS Biology. 19(12). e3001384–e3001384. 10 indexed citations

11.

Wajnberg, Ania, Fatima Amanat, Adolfo Firpo, et al.. (2020). Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science. 370(6521). 1227–1230. 648 indexed citations breakdown →

12.

Meade, Philip, Guillermina Kuan, Shirin Strohmeier, et al.. (2020). Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in Adults. mBio. 11(1). 48 indexed citations

13.

Amanat, Fatima, Kris M. White, Lisa Miorin, et al.. (2020). An In Vitro Microneutralization Assay for SARS‐CoV‐2 Serology and Drug Screening. Current Protocols in Microbiology. 58(1). e108–e108. 106 indexed citations

14.

Stadlbauer, Daniel, Fatima Amanat, Veronika Chromikova, et al.. (2020). SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup. Current Protocols in Microbiology. 57(1). e100–e100. 362 indexed citations

15.

Arunkumar, Guha Asthagiri, Andriani Ioannou, Teddy John Wohlbold, et al.. (2019). Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice. Journal of Virology. 93(6). 63 indexed citations

16.

Amanat, Fatima, Philip Meade, Shirin Strohmeier, & Florian Krammer. (2019). Cross-reactive antibodies binding to H4 hemagglutinin protect against a lethal H4N6 influenza virus challenge in the mouse model. Emerging Microbes & Infections. 8(1). 155–168. 21 indexed citations

17.

Sunwoo, Sun-Young, Michael Schotsaert, Igor Morozov, et al.. (2018). A Universal Influenza Virus Vaccine Candidate Tested in a Pig Vaccination-Infection Model in the Presence of Maternal Antibodies. Vaccines. 6(3). 64–64. 16 indexed citations

18.

Wohlbold, Teddy John, Kira A. Podolsky, Veronika Chromikova, et al.. (2017). Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes. Nature Microbiology. 2(10). 1415–1424. 99 indexed citations

19.

Stadlbauer, Daniel, Raffael Nachbagauer, Philip Meade, & Florian Krammer. (2017). Universal influenza virus vaccines: what can we learn from the human immune response following exposure to H7 subtype viruses?. Frontiers of Medicine. 11(4). 471–479. 8 indexed citations

20.

Meade, Philip, Neus Latorre‐Margalef, David E. Stallknecht, & Florian Krammer. (2017). Development of an influenza virus protein microarray to measure the humoral response to influenza virus infection in mallards. Emerging Microbes & Infections. 6(1). 1–9. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact